(PRWEB) September 21, 2012
Transvaginal Mesh Patches are made by at least nine different manufacturers, and are used in the vaginal wall to treat conditions that occur after childbirth and pregnancy. These patches are primarily used to treat two specific conditions, pelvic organ prolapse (POP) and stress urinary incontinence (SUI). POP and SUI affect millions of women, and the Transvaginal Mesh Patch is used in an attempt to repair the tissue damage these conditions cause.
When the United States Food and Drug Administration (FDA) first approved Transvaginal Mesh, it went through an approval process referred to as a 510(k). The primary requirement of this process is that the manufacturer shows that the product is substantially similar to a previously approved product. Therefore, very little is known about the long-term effectiveness and overall safety of the Transvaginal Mesh Patch. This has many people questioning the widespread use of these devices.
However, the FDA is now warning Transvaginal Mesh patients that the device is constantly failing and injuring implant recipients. These patients are experiencing numerous side effects, including:
Many of the patients experiencing these side effects require surgery to repair or remove the mesh, as well other forms of medical care.
The attorneys at d’Oliveira & Associates urge any one who has been injured by the Transvaginal Mesh Patch to contact them immediately. They are working with some of the leading defective medical device attorneys in the country who are handling these cases. They want to ensure that all potential Transvaginal Mesh clients understand that there is absolutely no fee unless a settlement is reached, or an award is won.
For a free legal consultation, call 1-800-992-6878 or visit their website at Transvaginal Mesh Patch Lawyers